Chapter 9 160 Table 1 Demographic Characteristics Baseline Characteristics Participants (n = 46) Nonparticipants (n = 45) P-value Age, mean (SD), y 53 (13.1) 66 (12.4) <.01 Male gender, n (%) 25 (54) 24 (53) .92 Scheduled intervention, n (%) .62 Change of pacemaker or ICD 14 (30) 18 (40) Pacemaker 3 9 ICD 11 8 S-ICD - 1 Implantation of pacemaker or ICD 18 (39) 16 (36) Pacemaker 2 4 ICD 14 11 S-ICD 2 1 PV isolation 14 (30) 11 (24) Comorbidity, n (%) Diabetes 3 (7) 11 (24) .02 Rheumatisma 0 (0) 4 (9) .04 Thyroid dysfunction 3 (7) 2 (4) .66 Adrenal suffering 0(0) 0 (0) - Medication, n (%) OAC 27 (59) 27 (61) .80 ASA 9 (20) 12 (27) .42 ASA and OAC 1 (2) 4 (9) .16 OAC AND LMWH 13 (28) 9 (20) .36 Living with partner, n (%) 27 (84) 10 (71) .31 Education, n (%) .89 Low 5 (16) 3 (21) Middle 12 (38) 5 (36) High 15 (47) 6 (43) Abbreviations: ASA, acetyl salicylic acid; ICD, implantable cardiac defibrillator; LMWH, low-molecular weight heparin; OAC, oral anti coagulation; PV, pulmonary veins. a. Rheumatism or connective tissue disease (data of 1 patient missing). Table 2 Interobserver Agreement per Case (N = 33) Valued by Nurse Practitioner 1 Valued by Nurse Practitioner 2 Agreement Quality, n (%) 33 33 Sufficient 32 29 29 (88) Insufficient 1 4 1 (3) Erythema, n (%) 29 29 Clinically irrelevant 28 27 27 (93) Clinically relevant 1 2 1 (3) Hematoma, n (%) 29 29 28 (96) Clinically irrelevant 29 28 28 (97) Clinically relevant - 1 - Conclusions, n (%) 29 29 Conservative therapy 28 27 27 (93) Clinical assessment 1 2 1 (3)
RkJQdWJsaXNoZXIy MTk4NDMw